{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:11:10Z","timestamp":1791159070908,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006301","name":"CIBER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.biocel.2014.07.017","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T01:31:46Z","timestamp":1406683906000},"page":"245-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease"],"prefix":"10.1016","volume":"54","author":[{"given":"Jenny","family":"Serra-Vinardell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Guti\u00e9rrez-de-Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gessam\u00ed","family":"S\u00e1nchez-Oll\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Bujons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Michelakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mavridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00efsa","family":"Vilageliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2014.07.017_bib0005","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0003-2697(86)90043-6","article-title":"A procedure for the rapid purification in high yield of human glucocerebrosidase using immunoaffinity chromatography with monoclonal antibodies","volume":"154","author":"Aerts","year":"1986","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bcmd.2005.05.007","article-title":"Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations","volume":"35","author":"Alfonso","year":"2005","journal-title":"Blood Cells Molecules and Diseases"},{"key":"10.1016\/j.biocel.2014.07.017_bib0015","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/prot.21554","article-title":"An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease","volume":"70","author":"Atrian","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.biocel.2014.07.017_bib0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcmd.2012.10.007","article-title":"Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase","volume":"50","author":"Bendikov-Bar","year":"2013","journal-title":"Blood Cells Molecules and Diseases"},{"key":"10.1016\/j.biocel.2014.07.017_bib0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/13543776.2011.569162","article-title":"Pharmacological chaperone therapy for Gaucher disease: a patent review","volume":"21","author":"Benito","year":"2011","journal-title":"Expert Opinion on Therapeutic Patients"},{"key":"10.1016\/j.biocel.2014.07.017_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/bcmd.1997.0114","article-title":"Hematologically important mutations: Gaucher disease","volume":"23","author":"Beutler","year":"1997","journal-title":"Blood Cells and Molecular Diseases"},{"key":"10.1016\/j.biocel.2014.07.017_bib0035","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1021\/jm301557k","article-title":"Pharmacological chaperones as therapeutics for lysosomal storage diseases","volume":"56","author":"Boyd","year":"2013","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0040","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/cbic.200900142","article-title":"6-Amino-6-deoxy-5,6-di-N-(N\u2032-octyliminomethylidene)nojirimycin: synthesis, biological evaluation, and crystal structure in complex with acid beta-glucosidase","volume":"10","author":"Brumshtein","year":"2009","journal-title":"Chembiochem"},{"key":"10.1016\/j.biocel.2014.07.017_bib0045","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1074\/jbc.M705005200","article-title":"Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease","volume":"282","author":"Brumshtein","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/glycob\/cwp138","article-title":"Characterization of gene-activated human acid-{beta}-glucosidase: crystal structure, glycan composition and internalization into macrophages","volume":"20","author":"Brumshtein","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.biocel.2014.07.017_bib0055","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1107\/S0907444906038303","article-title":"Structural comparison of differently glycosylated forms of acid-beta-glucosidase, the defective enzyme in Gaucher disease","volume":"62","author":"Brumshtein","year":"2006","journal-title":"Acta Crystallographica D Biological Crystallography"},{"key":"10.1016\/j.biocel.2014.07.017_bib0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bmc.2008.11.026","article-title":"Synthesis and biological properties of Pachastrissamine (jaspine B) and diastereoisomeric jaspines","volume":"17","author":"Canals","year":"2009","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0065","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/cbic.200600217","article-title":"Design and synthesis of highly potent and selective pharmacological chaperones for the treatment of Gaucher's disease","volume":"7","author":"Compain","year":"2006","journal-title":"Chembiochem"},{"key":"10.1016\/j.biocel.2014.07.017_bib0070","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.biocel.2014.07.017_bib0075","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS Journal"},{"key":"10.1016\/j.biocel.2014.07.017_bib0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcmd.2006.07.002","article-title":"RNAi-mediated inhibition of the glucosylceramide synthase (GCS) gene: a preliminary study towards a therapeutic strategy for Gaucher disease and other glycosphingolipid storage diseases","volume":"37","author":"Diaz-Font","year":"2006","journal-title":"Blood Cells and Molecular Diseases"},{"key":"10.1016\/j.biocel.2014.07.017_bib0085","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1021\/jm100198t","article-title":"Click chemistry approach to new N-substituted aminocyclitols as potential pharmacological chaperones for Gaucher disease","volume":"53","author":"Diaz","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1021\/ci100453a","article-title":"Computational prediction of structure-activity relationships for the binding of aminocyclitols to beta-glucocerebrosidase","volume":"51","author":"D\u00edaz","year":"2011","journal-title":"Journad of Chemical Information and Modeling"},{"key":"10.1016\/j.biocel.2014.07.017_bib0095","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.embor.embor873","article-title":"X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease","volume":"4","author":"Dvir","year":"2003","journal-title":"EMBO Reports"},{"key":"10.1016\/j.biocel.2014.07.017_bib0100","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.0606016103","article-title":"Effective cell and gene therapy in a murine model of Gaucher disease","volume":"103","author":"Enquist","year":"2006","journal-title":"Proceedings of the National Academy of Science of the United States of America"},{"key":"10.1016\/j.biocel.2014.07.017_bib0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0165-6147(03)00158-5","article-title":"A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity","volume":"24","author":"Fan","year":"2003","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.biocel.2014.07.017_bib0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tips.2004.01.004","article-title":"New directions in the treatment of Gaucher disease","volume":"25","author":"Futerman","year":"2004","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.biocel.2014.07.017_bib0115","series-title":"New Sphingolipid Probes for Metabolism and Trafficking Studies: Doctoral Thesis","author":"Garrido","year":"2012"},{"key":"10.1016\/j.biocel.2014.07.017_bib0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12154-012-0075-0","article-title":"In situ synthesis of fluorescent membrane lipids (ceramides) using click chemistry","volume":"5","author":"Garrido","year":"2012","journal-title":"Journal of Chemical Biology"},{"key":"10.1016\/j.biocel.2014.07.017_bib0125","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/jm201633y","article-title":"Rapid assembly of a library of lipophilic iminosugars via the thiol\u2013ene reaction yields promising pharmacological chaperones for the treatment of Gaucher disease","volume":"55","author":"Goddard-Borger","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/gte.1997.1.5","article-title":"Gaucher disease: gene frequencies and genotype\/phenotype correlations","volume":"1","author":"Grabowski","year":"1997","journal-title":"Genetic Testing"},{"key":"10.1016\/j.biocel.2014.07.017_bib0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1517\/14728214.13.1.197","article-title":"Treatment perspectives for the lysosomal storage diseases","volume":"13","author":"Grabowski","year":"2008","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"10.1016\/j.biocel.2014.07.017_bib0140","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1016\/j.bmcl.2007.08.050","article-title":"N4-Phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease","volume":"17","author":"Huang","year":"2007","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"key":"10.1016\/j.biocel.2014.07.017_bib0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD - visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"Journal of Molecular Graphics"},{"key":"10.1016\/j.biocel.2014.07.017_bib0150","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1021\/jo00090a035","article-title":"An efffective strategy for the synthesis os 6-O-(2-amino-2-deoxy-\u03b1-D-glucopyranosyl)-D-chiro- and -D-myo-inositol 1-phosphate related to putative insulin mimetics","volume":"59","author":"Jaramillo","year":"1994","journal-title":"Journal of Organic Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0155","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"Journal of Chemical Physics"},{"key":"10.1016\/j.biocel.2014.07.017_bib0160","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.biocel.2014.07.017_bib0165","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"Journal of Physical Chemistry B"},{"key":"10.1016\/j.biocel.2014.07.017_bib0170","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1742-4658.2010.07588.x","article-title":"The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase","volume":"277","author":"Khanna","year":"2010","journal-title":"FEBS Journal"},{"key":"10.1016\/j.biocel.2014.07.017_bib0175","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","article-title":"Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability","volume":"48","author":"Lieberman","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","article-title":"Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease","volume":"3","author":"Lieberman","year":"2007","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.biocel.2014.07.017_bib0185","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme-enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2818.1993.tb03313.x","article-title":"Measurement of co-localization of objects in dual-colour confocal images","volume":"169","author":"Manders","year":"1993","journal-title":"Journal of Microscopy"},{"key":"10.1016\/j.biocel.2014.07.017_bib0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1039\/C1MD00200G","article-title":"Non-iminosugar glucocerebrosidase small molecule chaperones","volume":"3","author":"Marugan","year":"2012","journal-title":"MedChemComm"},{"key":"10.1016\/j.biocel.2014.07.017_bib0200","doi-asserted-by":"crossref","DOI":"10.1021\/jm1008902","article-title":"Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity","author":"Marugan","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0205","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jgm.901","article-title":"AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease","volume":"8","author":"McEachern","year":"2006","journal-title":"The Journal od Gene Medicine"},{"key":"10.1016\/j.biocel.2014.07.017_bib0215","doi-asserted-by":"crossref","first-page":"42105","DOI":"10.1074\/jbc.M110.172098","article-title":"Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S","volume":"285","author":"Offman","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cmdc.201000469","article-title":"Second-generation iminoxylitol-based pharmacological chaperones for the treatment of Gaucher disease","volume":"6","author":"Oulaidi","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biocel.2014.07.017_bib0225","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/j.biocel.2014.07.017_bib0230","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"Journal of Computational Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0235","doi-asserted-by":"crossref","first-page":"2381 5","DOI":"10.1074\/jbc.M502799200","article-title":"X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease","volume":"280","author":"Premkumar","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ymgme.2008.12.008","article-title":"Diltiazem, a L-type Ca2+ channel blocker, also acts as a pharmacological chaperone in Gaucher patient cells","volume":"96","author":"Rigat","year":"2009","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/j.biocel.2014.07.017_bib0245","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/jbiol186","article-title":"What are pharmacological chaperones and why are they interesting?","volume":"8","author":"Ringe","year":"2009","journal-title":"Journal of Biology"},{"key":"10.1016\/j.biocel.2014.07.017_bib0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bcmd.2008.11.002","article-title":"Promising results of the chaperone effect caused by iminosugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease","volume":"42","author":"Sanchez-Olle","year":"2009","journal-title":"Blood Cells and Molecular Diseases"},{"key":"10.1016\/j.biocel.2014.07.017_bib0255","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chemistry & Biology"},{"key":"10.1016\/j.biocel.2014.07.017_bib0260","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proceedings of the National Academy of Science of the United States of America"},{"key":"10.1016\/j.biocel.2014.07.017_bib0265","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.biocel.2014.07.017_bib0270","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.biocel.2005.05.008","article-title":"Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease","volume":"37","author":"Schmitz","year":"2005","journal-title":"The International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.biocel.2014.07.017_bib0275","unstructured":"Schr\u00f6dinger. MacroModel, version 9.9. New York, NY: Schr\u00f6dinger, LLC; 2011a."},{"key":"10.1016\/j.biocel.2014.07.017_bib0280","unstructured":"Schr\u00f6dinger. Maestro, version 9.2. New York, NY: Schr\u00f6dinger, LLC; 2011b."},{"key":"10.1016\/j.biocel.2014.07.017_bib0285","unstructured":"Schr\u00f6dinger. Suite 2011. New York, NY: Schr\u00f6dinger, LLC; 2011c."},{"key":"10.1016\/j.biocel.2014.07.017_bib0290","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1467-7652.2007.00263.x","article-title":"Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system","volume":"5","author":"Shaaltiel","year":"2007","journal-title":"Plant Biotechnology Journal"},{"key":"10.1016\/j.biocel.2014.07.017_bib0295","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proceedings of the National Academy of Science of the United States of America"},{"key":"10.1016\/j.biocel.2014.07.017_bib0300","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1021\/ja00172a038","article-title":"Semianalytical treatment of solvation for molecular mechanics and dynamics","volume":"112","author":"Still","year":"1990","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.biocel.2014.07.017_bib9005","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1074\/jbc.M111.280016","article-title":"Ex vivo and in vivo effects of isofagomine on acid \u03b2-glucosidase variants and substrate levels in Gaucher disease","volume":"287","author":"Sun","year":"2012","journal-title":"Journal Biological Chememistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.braindev.2012.12.002","article-title":"Chaperone therapy update: Fabry disease, G(M1)-ganglisidosis and Gaucher disease","author":"Suzuki","year":"2013","journal-title":"Brain and Development"},{"key":"10.1016\/j.biocel.2014.07.017_bib0310","doi-asserted-by":"crossref","first-page":"32655","DOI":"10.1074\/jbc.M702387200","article-title":"Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis","volume":"282","author":"Walden","year":"2007","journal-title":"Journal od Biological Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0315","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1021\/jm801506m","article-title":"Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease","volume":"52","author":"Wang","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0320","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1074\/jbc.M110.150433","article-title":"X-ray and biochemical analysis of N370S mutant human acid beta-glucosidase","volume":"286","author":"Wei","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0325","unstructured":"Weinreb NJ. A phase 2 clinical trial of the pharmacological chaperone AT-2101 for the treatment of Gaucher disease. 8th European Working Group on Gaucher Disease (EWGGD) Meeting. Budapest 2008."},{"key":"10.1016\/j.biocel.2014.07.017_bib0330","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.1016\/j.bmc.2006.08.003","article-title":"alpha-1-C-Octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease","volume":"14","author":"Yu","year":"2006","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0335","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1021\/jm060677i","article-title":"2,5-Anhydro-2,5-imino-d-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention","volume":"50","author":"Yu","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.biocel.2014.07.017_bib0340","doi-asserted-by":"crossref","first-page":"13192","DOI":"10.1073\/pnas.0705637104","article-title":"Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease","volume":"104","author":"Zheng","year":"2007","journal-title":"Proceedings of the National Academy of Science of the United States of America"},{"key":"10.1016\/j.biocel.2014.07.017_bib0345","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","article-title":"Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)","volume":"188","author":"Zimmer","year":"1999","journal-title":"Journal of Pathology"}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272514002465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272514002465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:58:27Z","timestamp":1761202707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272514002465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":69,"alternative-id":["S1357272514002465"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2014.07.017","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2014.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}